Biostar Pharmaceuticals Correlations

BSPMDelisted Stock  USD 0.01  0.00  0.00%   
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biostar Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biostar Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
  
The ability to find closely correlated positions to Biostar Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biostar Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biostar Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biostar Pharmaceuticals to buy it.

Moving together with Biostar Pink Sheet

  1.0HMGN Hemagen DiagnosticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AGRXATNX
LSDIATNX
LSDIAGRX
AGRXMNK
KMDALFCR
ATNXMNK
  
High negative correlations   
MNKLFCR
AGRXLFCR
ALIMAGRX
AGRXKMDA
MNKKMDA
ALIMMNK

Risk-Adjusted Indicators

There is a big difference between Biostar Pink Sheet performing well and Biostar Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biostar Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LFCR  3.10  0.56  0.14  0.49  3.65 
 8.08 
 20.91 
KMDA  1.20  0.16  0.06  0.56  1.22 
 3.04 
 7.43 
SHPH  4.44 (0.74) 0.00  2.38  0.00 
 8.93 
 50.96 
CPIX  4.26  1.58  0.41 (1.57) 2.25 
 4.76 
 30.57 
IRWD  3.52 (0.29) 0.00  0.00  0.00 
 6.62 
 20.41 
MNK  16.59 (0.32) 0.10  0.10  13.99 
 12.50 
 504.19 
ATNX  13.35 (4.40) 0.00 (1.00) 0.00 
 25.00 
 143.13 
AGRX  3.20 (1.17) 0.00 (5.48) 0.00 
 7.63 
 19.82 
LSDI  298.43  161.12  3.23 (1.75) 27.98 
 550.00 
 3,998 
ALIM  2.74  1.01  0.64  0.53  0.37 
 3.28 
 82.36 

Biostar Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biostar Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Biostar Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Biostar Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Biostar Pharmaceuticals Corporate Management

Zhenghong WangChief OfficerProfile
Pr ZhengChief ScientistProfile
Xiaojuan ZhaiChief OfficerProfile
Shuang GongSecretary of BoardProfile

Still Interested in Biostar Pharmaceuticals?

Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.